Your browser doesn't support javascript.
loading
A Randomized Clinical Trial of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection.
Doberer, Konstantin; Duerr, Michael; Halloran, Philip F; Eskandary, Farsad; Budde, Klemens; Regele, Heinz; Reeve, Jeff; Borski, Anita; Kozakowski, Nicolas; Reindl-Schwaighofer, Roman; Waiser, Johannes; Lachmann, Nils; Schranz, Sabine; Firbas, Christa; Mühlbacher, Jakob; Gelbenegger, Georg; Perkmann, Thomas; Wahrmann, Markus; Kainz, Alexander; Ristl, Robin; Halleck, Fabian; Bond, Gregor; Chong, Edward; Jilma, Bernd; Böhmig, Georg A.
  • Doberer K; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • Duerr M; Department of Nephrology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Halloran PF; Alberta Transplant Applied Genomics Centre, University of Alberta, Edmonton, Alberta, Canada.
  • Eskandary F; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • Budde K; Department of Nephrology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Regele H; Department of Clinical Pathology, Medical University of Vienna, Vienna, Austria.
  • Reeve J; Alberta Transplant Applied Genomics Centre, University of Alberta, Edmonton, Alberta, Canada.
  • Borski A; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • Kozakowski N; Department of Clinical Pathology, Medical University of Vienna, Vienna, Austria.
  • Reindl-Schwaighofer R; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • Waiser J; Department of Nephrology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Lachmann N; Centre for Tumor Medicine, Histocompatibility & Immunogenetics Laboratory, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Schranz S; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Firbas C; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Mühlbacher J; Department of Surgery, Medical University of Vienna, Vienna, Austria.
  • Gelbenegger G; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Perkmann T; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Wahrmann M; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • Kainz A; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • Ristl R; Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
  • Halleck F; Department of Nephrology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Bond G; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • Chong E; Vitaeris Inc., Vancouver, Canada.
  • Jilma B; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Böhmig GA; Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
J Am Soc Nephrol ; 32(3): 708-722, 2021 03.
Article en En | MEDLINE | ID: mdl-33443079

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Interleucina-6 / Trasplante de Riñón / Anticuerpos Monoclonales Humanizados / Rechazo de Injerto Tipo de estudio: Clinical_trials / Etiology_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Interleucina-6 / Trasplante de Riñón / Anticuerpos Monoclonales Humanizados / Rechazo de Injerto Tipo de estudio: Clinical_trials / Etiology_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article